Meeting
2023 ASCO Genitourinary Cancers Symposium
Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC).
Authors
Amanda Broderick
Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, NC
Amanda Broderick , Jinju Li , Alec Chu , Clara Hwang , Pedro C. Barata , Frank Cameron Cackowski , Matthew Labriola , Alyssa Ghose , Mehmet Asim Bilen , Deepak Kilari , Laura Graham , Abhishek Tripathi , Rohan Garje , Vadim S Koshkin , Elizabeth Pan , Tanya B. Dorff , Rana R. McKay , Michael Thomas Schweizer , Ajjai Shivaram Alva , Andrew J. Armstrong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 229)
DOI
10.1200/JCO.2023.41.6_suppl.229
Abstract #
229
Poster Bd #
H15
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Characterization of Wnt signaling pathway (WSP) aberrations in advanced prostate cancer.
First Author: Fady Ghali
Poster
2022 ASCO Annual Meeting
Characterization and impact of canonical Wnt Signaling Pathway (WSP) alterations on outcomes of metastatic prostate cancer.
First Author: Rana R. McKay
Poster
2019 ASCO Annual Meeting
WNT activating pathway mutations confer resistance to first-line antiandrogen therapy in castration-resistant prostate cancer (CRPC).
First Author: Pedro Isaacsson Velho
Poster
2024 ASCO Genitourinary Cancers Symposium
Canonical Wnt signaling pathway (WSP) alterations in metastatic prostate cancer.
First Author: Sharon Choi